Home » AFFECTIS PHARMACEUTICALS AG RECEIVES STATE GRANTS FOR THE DEVELOPMENT OF NOVEL ANTIDEPRESSANTS
AFFECTIS PHARMACEUTICALS AG RECEIVES STATE GRANTS FOR THE DEVELOPMENT OF NOVEL ANTIDEPRESSANTS
Affectis Pharmaceuticals AG today announced that it has received two research grants totalling € 2.2 million to broaden and progress its proprietary drug discovery and development programmes. The Company has secured € 1.7 million from the German Federal Ministry of Education and Research (BMBF) to develop novel drug candidates targeting a specific ion channel that is exclusively explored by Affectis Pharmaceuticals.
Biotech Intelligence (http://www.biotech-intelligence.com/html/html/a6b6e7cf9987d406073047ce578d03f7.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May